Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | Ulixertinib | 1.0 | 0.5361 | 0.04088 |
| HCC1143 | Ulixertinib | 1.0 | 0.8286 | 0.01419 |
| HCC1143 | Ulixertinib | 3.16227766 | 0.4101 | 0.04743 |
| HCC1143 | Ulixertinib | 3.16227766 | 0.3418 | 0.02595 |
| HCC1143 | Ulixertinib | 3.16227766 | 0.5524 | 0.01863 |
| HCC1143 | Ulixertinib | 10.0 | 0.0472 | 0.08498 |
| HCC1143 | Ulixertinib | 10.0 | 0.1532 | 0.05538 |
| HCC1143 | Ulixertinib | 10.0 | 0.0344 | 0.08151 |
| HCC1143 | Alvocidib | 0.0001 | 1.0177 | -0.00582 |
| HCC1143 | Alvocidib | 0.0001 | 1.0322 | -0.00311 |
| HCC1143 | Alvocidib | 0.0001 | 1.0051 | -0.01287 |
| HCC1143 | Alvocidib | 0.000316227766017 | 0.9674 | 0.00123 |
| HCC1143 | Alvocidib | 0.000316227766017 | 1.0520 | 0.00267 |
| HCC1143 | Alvocidib | 0.000316227766017 | 1.0493 | -0.00671 |
| HCC1143 | Alvocidib | 0.001 | 0.9861 | -0.00006 |
| HCC1143 | Alvocidib | 0.001 | 0.9014 | -0.00609 |
| HCC1143 | Alvocidib | 0.001 | 0.9670 | -0.00565 |
| HCC1143 | Alvocidib | 0.00316227766017 | 0.9546 | 0.00790 |
| HCC1143 | Alvocidib | 0.00316227766017 | 0.9381 | 0.00361 |
| HCC1143 | Alvocidib | 0.00316227766017 | 1.1160 | -0.00963 |
| HCC1143 | Alvocidib | 0.01 | 0.9239 | -0.00059 |
| HCC1143 | Alvocidib | 0.01 | 0.9857 | 0.00348 |
| HCC1143 | Alvocidib | 0.01 | 1.0035 | 0.01526 |
| HCC1143 | Alvocidib | 0.0316227766017 | 0.9376 | 0.00062 |
| HCC1143 | Alvocidib | 0.0316227766017 | 0.9336 | -0.00465 |